Adaptive Biotechnologies Corp

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ADPT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

202,725

Value ($000)

3,292

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,292	0.0%	202,725	12/31/2025
2025 Q3	11/14/2025	2,164	0.0%	144,635	9/30/2025
2025 Q2	8/14/2025	3,109	0.0%	266,893	6/30/2025
2025 Q1	5/19/2025	1,376	0.0%	185,236	3/31/2025
2024 Q4	2/14/2025	711	0.0%	118,593	12/31/2024
2024 Q1	5/15/2024	655	0.0%	203,941	3/31/2024
2023 Q4	2/14/2024	839	0.0%	171,292	12/31/2023
2023 Q3	11/13/2023	934	0.0%	171,292	9/30/2023
2023 Q2	8/11/2023	1,085	0.0%	122,917	6/30/2023
2023 Q1	5/15/2023	1,085	0.0%	122,917	3/31/2023
2022 Q4	2/14/2023	857	0.0%	112,186	12/31/2022
2022 Q3	11/14/2022	781	0.0%	109,729	9/30/2022
2022 Q2	8/12/2022	861	0.0%	106,400	6/30/2022
2022 Q1	5/16/2022	2,382	0.0%	171,643	3/31/2022
2021 Q4	2/14/2022	4,359	0.0%	155,358	12/31/2021
2021 Q3	11/15/2021	5,126	0.0%	150,800	9/30/2021
2021 Q2	8/16/2021	6,064	0.0%	148,406	6/30/2021
2021 Q1	5/14/2021	11,237	0.0%	279,121	3/31/2021
2020 Q4	3/1/2021	16,424	0.0%	277,757	12/31/2020
2020 Q3	11/13/2020	11,938	0.0%	245,491	9/30/2020
2020 Q2	8/14/2020	11,355	0.0%	234,712	6/30/2020
2020 Q1	5/15/2020	1,776	0.0%	63,946	3/31/2020
2019 Q4	2/14/2020	1,527	0.0%	51,023	12/31/2019